Literature DB >> 22407827

TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Sergio Duarte1, Takashi Hamada, Naohisa Kuriyama, Ronald W Busuttil, Ana J Coito.   

Abstract

UNLABELLED: Hepatic ischemia and reperfusion injury (IRI) remains an important challenge in clinical orthotopic liver transplantation (OLT). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is the major endogenous regulator of matrix metalloproteinase-9 (MMP-9). In this study we investigated the functional significance of TIMP-1 expression in a well-established mouse model of partial liver IRI. Compared to wildtype mice, TIMP-1(-/-) mice showed further impaired liver function and histological preservation after IRI. Notably, TIMP-1 deficiency led to lethal liver IRI, as over 60% of the TIMP-1(-/-) mice died postreperfusion, whereas all TIMP-1(+/+) mice recovered and survived surgery. Lack of TIMP-1 expression was accompanied by markedly high levels of MMP-9 activity, which facilitates leukocyte transmigration across vascular barriers in hepatic IRI. Indeed, TIMP-1(-/-) livers were characterized by massive leukocyte infiltration and by up-regulation of proinflammatory mediators, including tumor necrosis factor alpha, interferon-gamma, and inducible nitric oxide synthase post-IRI. The inability of TIMP-1(-/-) mice to express TIMP-1 increased the levels of active caspase-3 and depressed the expression of Bcl-2 and the phosphorylation of Akt, emphasizing an important role for TIMP-1 expression on hepatocyte survival. Using independent parameters of regeneration, 5-bromodeoxyuridine incorporation, proliferating cell nuclear antigen expression, and histone H3 phosphorylation, we provide evidence that hepatocyte progression into S phase and mitosis was impaired in TIMP-1-deficient livers after IRI. Inhibition of the cell cycle progression by TIMP-1 deficiency was linked to depressed levels of cyclins-D1 and -E and to a disrupted c-Met signaling pathway, as evidenced by reduced phosphorylated c-Met expression and elevated c-Met ectodomain shedding postliver IRI.
CONCLUSION: These results support a critical protective function for TIMP-1 expression on promoting survival and proliferation of liver cells and on regulating leukocyte recruitment and activation in liver IRI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407827      PMCID: PMC3386467          DOI: 10.1002/hep.25710

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 2.  Novel functions of TIMPs in cell signaling.

Authors:  Rosemarie Chirco; Xu-Wen Liu; Ki-Kyung Jung; Hyeong-Reh Choi Kim
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

3.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.

Authors:  Peter J Gough; Ivan G Gomez; Paul T Wille; Elaine W Raines
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

4.  Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration.

Authors:  Fazilat F Mohammed; Caroline J Pennington; Zamaneh Kassiri; Jeffrey S Rubin; Paul D Soloway; Ulrich Ruther; Dylan R Edwards; Rama Khokha
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

5.  Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  Gwénola Boulday; Juliette Fitau; Stéphanie Coupel; Jean-Paul Soulillou; Béatrice Charreau
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 6.  Gelatinase-mediated migration and invasion of cancer cells.

Authors:  Mikael Björklund; Erkki Koivunen
Journal:  Biochim Biophys Acta       Date:  2005-04-12

Review 7.  Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.

Authors:  Ana J Coito
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

8.  Platelet-derived serotonin mediates liver regeneration.

Authors:  Mickael Lesurtel; Rolf Graf; Boris Aleil; Diego J Walther; Yinghua Tian; Wolfram Jochum; Christian Gachet; Michael Bader; Pierre-Alain Clavien
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

Review 9.  Apoptosis and necrosis in the liver: a tale of two deaths?

Authors:  Harmeet Malhi; Gregory J Gores; John J Lemasters
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

10.  Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.

Authors:  Annalisa Petrelli; Paola Circosta; Luisa Granziero; Massimiliano Mazzone; Alberto Pisacane; Silvia Fenoglio; Paolo M Comoglio; Silvia Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

View more
  23 in total

1.  Cell-specific translational profiling in acute kidney injury.

Authors:  Jing Liu; A Michaela Krautzberger; Shannan H Sui; Oliver M Hofmann; Ying Chen; Manfred Baetscher; Ivica Grgic; Sanjeev Kumar; Benjamin D Humphreys; Benjamin Humphreys; Winston A Hide; Andrew P McMahon
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

2.  MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.

Authors:  Hiroyuki Kato; Naohisa Kuriyama; Sergio Duarte; Pierre-Alain Clavien; Ronald W Busuttil; Ana J Coito
Journal:  J Hepatol       Date:  2014-01-08       Impact factor: 25.083

Review 3.  Matrix Metalloproteinases (MMPs) in Liver Diseases.

Authors:  Adnan Naim; Qiuwei Pan; Mirza S Baig
Journal:  J Clin Exp Hepatol       Date:  2017-10-03

4.  Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.

Authors:  Sergio Duarte; Patrick Matian; Stacy Ma; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2018-06-02       Impact factor: 4.307

5.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

6.  Investigation of the underlying hub genes and mechanisms of reperfusion injury in patients undergoing coronary artery bypass graft surgery by integrated bioinformatic analyses.

Authors:  Zhida Shen; Jiangting Lu; Jiejin Wei; Juanjuan Zhao; Meihui Wang; Ming Wang; Xiaohua Shen; Xue Lü; Binquan Zhou; Yanbo Zhao; Guosheng Fu
Journal:  Ann Transl Med       Date:  2019-11

Review 7.  Matrix metalloproteinases in liver injury, repair and fibrosis.

Authors:  Sergio Duarte; John Baber; Takehiro Fujii; Ana J Coito
Journal:  Matrix Biol       Date:  2015-01-16       Impact factor: 11.583

8.  In situ transverse rectus abdominis myocutaneous flap: a rat model of myocutaneous ischemia reperfusion injury.

Authors:  Marie-Claire Edmunds; Stephen Wigmore; David Kluth
Journal:  J Vis Exp       Date:  2013-06-08       Impact factor: 1.355

9.  Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.

Authors:  Yosuke Osawa; Masato Hoshi; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Osamu Kozawa
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.

Authors:  Lisa A Ridnour; Kimberly M Barasch; Alisha N Windhausen; Tiffany H Dorsey; Michael M Lizardo; Harris G Yfantis; Dong H Lee; Christopher H Switzer; Robert Y S Cheng; Julie L Heinecke; Ernst Brueggemann; Harry B Hines; Chand Khanna; Sharon A Glynn; Stefan Ambs; David A Wink
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.